01/12/2021

ProductLife joins EuropaBio: improving human health by delivering regulatory compliance services for the safe and effective use of medical solutions

EuropaBio is pleased to announce that Olon has joined as an associate member.
22/11/2021

The review of the general pharmaceutical legislation: an opportunity that should not be missed?

08/11/2021

What is the use of innovation if it cannot be implemented? Or why consumers have the last word

03/11/2021

EuropaBio sat down with New Member Olon, to find out about their Plans to Expand their Biotechnology Platform

EuropaBio sat down with New Member Olon, to find out about their Plans to Expand their Biotechnology Platform.
26/10/2021

Healthy Planet, Healthy People: a Pathway for Green Transition in the Biopharmaceutical Ecosystem

20/10/2021

EuropaBio sat down with new Member Puratos, to find out the secret behind their centenary success

EuropaBio sat down with new Member Puratos to find out the secret behind their centenary success.
19/10/2021

EuropaBio Patient Bio-Forum: challenges and future potential of European Reference Networks

18/10/2021

European Biotech Week 2021: Telling the stories of European Biotechnology

14/10/2021

EuropaBio sat down with new Member IFF, to find out about their focus on health and well-being, product performance, and user satisfaction

EuropaBio sat down with new Member to find out about their focus on health and well-being, product performance, and user satisfaction.
30/09/2021

Artificial intelligence: investing in new technologies in healthcare

What if machine learning and artificial intelligence could learn to detect one of the most common forms of blood cancer, through evaluating data based on the gene activity of blood cells?
27/09/2021

Europe celebrates life science with European Biotech Week 2021

08/09/2021

Treatment Without Borders: The EU Case for Equitable Patient Access to Advanced Therapies

02/08/2021

EuropaBio response to the European Commission Public Consultation on the Regulations for Orphan Medicinal Products and Paediatrics

EuropaBio has responded to the European Commission’s public consultation on the Orphan Medicinal Products (OMPs) and Paediatrics Regulations.
29/07/2021

EuropaBio response to the Public Consultation ‘Digital Health Data and Services – The European Health Data Space’

26/07/2021

EuropaBio response to the European Commission Public Consultation on the Regulation for Orphan Medicinal Products and Paediatrics: the value brought by the technology to patients and society should be well recognised

22/07/2021

Call for tender: EuropaBio requires Maintenance and Development Services for its four Websites

20/07/2021

EuropaBio’s response to the EC consultation on patients’ rights in cross-border healthcare

03/07/2021

EuropaBio Members nominate Europe’s biotechnology landmarks from the last 25 years

We, the undersigned CEOs of global biotechnology companies and associations have a social responsibility to work with other stakeholders to ensure that COVID vaccines and treatments get to the patients in the world who most need them.
29/06/2021

A Declaration from Members of the World’s Biotechnology Sector On Global Access to COVID Vaccines & Treatments and the Role of Intellectual Property

We, the undersigned CEOs of global biotechnology companies and associations have a social responsibility to work with other stakeholders to ensure that COVID vaccines and treatments get to the patients in the world who most need them.
29/06/2021

EV Biotech joins EuropaBio: effective, bio-based alternatives to conventional chemical-synthetic production processes

EuropaBio is pleased to announce that EV Biotech has joined the organization as an Associate Member.
Become a member